Next Generation Sequencing Analysis and its Benefit for Targeted Therapy of Lung Adenocarcinoma.

As lung adenocarcinoma patients significantly benefit from targeted therapy, the assessment of mutational profiles using NGS could become a crucial approach in the routine management of oncological patients.